Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus propofol for postoperative sedation in cardiac surgery ICU patients
ChiCTR2400081043Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Feb 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofol, propofol and remifentanil in sedation and postoperative pain (2 arms), sponsored by Xuzhou Central Hospital. Primary endpoints: Percentage of time within target sedation range without additional sedation, Incidence of safety events and 3 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
ciprofolpropofolremifentanil
03
Conditions
sedationpostoperative pain
Beyond the preview
Go deeper on ChiCTR2400081043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081043.